NuVasive Announces First Patient in Japan Treated with XLIF(R) Technique
Posted on February 26, 2013 at 16:17 PM EST
NuVasive, Inc. (NASDAQ: NUVA ), a medical device company focused on developing minimally disruptive surgical products and procedures for the spine, is proud to announce that the very first eXtreme Lateral Interbody Fusion (XLIF(R)) procedures were performed yesterday and today at two different hospitals in Japan. NuVasive has received regulatory Shonin approval for